For decades, pharma has been a race against time. Drug discovery takes years. Clinical trials take years. Regulatory approvals take years. And for every 10,000 molecules explored, perhaps one reaches the market, at an investment of billions of dollars. Meanwhile, patientstoday, living in the Blinkit age, expect instant results, personalised therapies, and better outcomes. In […]